Cambridge’s DIOSynVax and Singapore’s ACM Biolabs to Advance Pandemic-Ready Universal Bird Flu Vaccine with International Support
CAMBRIDGE, United Kingdom and SINGAPORE, April 22, 2025 (GLOBE NEWSWIRE) — Cambridge’s DIOSynVax and Singapore’s ACM Biolabs will be jointly…